Literature DB >> 16896895

Morphometric sum optical density as a surrogate marker for ploidy status in prostate cancer: an analysis in 180 biopsies using logistic regression and binary recursive partitioning.

Girish Venkataraman1, Vijayalakshmi Ananthanarayanan, Gladell P Paner, Rui He, Saeedeh Masoom, James Sinacore, Robert C Flanigan, Eva M Wojcik.   

Abstract

We sought to identify morphometric descriptors predictive of nondiploidy in prostatic adenocarcinoma on prostate needle biopsies using logistic regression (LR) and binary recursive partitioning (BRP) and compare the equivalence of both methods. A total of 180 prostate needle biopsies diagnosed as prostatic adenocarcinoma were selected. Deoxyribonucleic acid ploidy and morphometry were performed separately on Feulgen-stained sections from these biopsies using the CAS-200 system and Nuclear Morphometry Suite, respectively. Seven morphometric predictors were tested as predictor variables, including nuclear area, circularity, elongation, sum optical density (OD), configuration run length, coefficient of variation (CV), and angularity. Logistic regression (LR) identified a two-parameter model including sum OD and circularity that had a 93.9% overall correct prediction rate (area under curve=0.950; 95% CI: 0.913, 0.987). A reduced model including only sum OD was equally good without any significant loss of predictive accuracy (93.3% correct overall classification rate). BRP also selected sum OD as the most predictive parameter; a sum OD cut-off of 7.73 in this model identified 93.3% of the nondiploid cases correctly. Morphometric OD can be used as a surrogate marker of nondiploidy. LR and BRP models are both equivalent in identifying and correctly classifying nondiploid cases of prostate cancer using sum OD as the predictor variable.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16896895     DOI: 10.1007/s00428-006-0237-y

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  13 in total

1.  Morphometry of nuclei of the normal and malignant prostate in relation to DNA ploidy.

Authors:  N Wang; B G Stenkvist; B Tribukait
Journal:  Anal Quant Cytol Histol       Date:  1992-06       Impact factor: 0.302

2.  Using nuclear morphometry to discriminate the tumorigenic potential of cells: a comparison of statistical methods.

Authors:  Pamela Wolfe; James Murphy; John McGinley; Zongjian Zhu; Weiqin Jiang; E Brigitte Gottschall; Henry J Thompson
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2004-06       Impact factor: 4.254

Review 3.  DNA ploidy analysis in histopathology. Morphometry and DNA cytometry reproducibility conditions and clinical applications.

Authors:  J P A Baak; E Janssen
Journal:  Histopathology       Date:  2004-06       Impact factor: 5.087

4.  [Prognostic value of DNA ploidy and nuclear morphometry in metastatic prostate cancer].

Authors:  J M Martínez Jabaloyas; A Jiménez Sánchez; J L Ruiz Cerdá; S Sanz Chinesta; A Sempere; J F Jiménez Cruz
Journal:  Actas Urol Esp       Date:  2004-04       Impact factor: 0.994

Review 5.  Correlation of prostate cancer nuclear deoxyribonucleic acid, size, shape and Gleason grade with pathological stage at radical prostatectomy.

Authors:  J I Epstein; G Pizov; G D Steinberg; H B Carter; R Pitcock; O A Armas; A Partin; P C Walsh
Journal:  J Urol       Date:  1992-07       Impact factor: 7.450

6.  Comparison of quantitative histomorphometry and DNA ploidy in tissue sections of prostate carcinoma.

Authors:  Paul A Kay; Darren L Riehle; John C Cheville; Christine M Lohse; V Shane Pankratz; Eunice M Hill; Thomas J Sebo
Journal:  Anal Quant Cytol Histol       Date:  2002-02       Impact factor: 0.302

7.  Ability to predict biochemical progression using Gleason score and a computer-generated quantitative nuclear grade derived from cancer cell nuclei.

Authors:  R W Veltri; M C Miller; A W Partin; D S Coffey; J I Epstein
Journal:  Urology       Date:  1996-11       Impact factor: 2.649

8.  Prognostic factors for survival of patients with pathological Gleason score 7 prostate cancer: differences in outcome between primary Gleason grades 3 and 4.

Authors:  W K Lau; M L Blute; D G Bostwick; A L Weaver; T J Sebo; H Zincke
Journal:  J Urol       Date:  2001-11       Impact factor: 7.450

9.  Quantitative alterations in nuclear structure predict prostate carcinoma distant metastasis and death in men with biochemical recurrence after radical prostatectomy.

Authors:  Masood A Khan; Patrick C Walsh; M Craig Miller; Wesley D Bales; Jonathan I Epstein; Leslie A Mangold; Alan W Partin; Robert W Veltri
Journal:  Cancer       Date:  2003-12-15       Impact factor: 6.860

10.  Quantitative nuclear morphometry, Markovian texture descriptors, and DNA content captured on a CAS-200 Image analysis system, combined with PCNA and HER-2/neu immunohistochemistry for prediction of prostate cancer progression.

Authors:  R W Veltri; A W Partin; J E Epstein; G M Marley; C M Miller; D S Singer; K P Patton; S R Criley; D S Coffey
Journal:  J Cell Biochem Suppl       Date:  1994
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.